Study for small fatty lumps under the skin
Part of Cancer clinical trials.
This trial is testing a treatment for small, non-cancerous fatty lumps (lipomas) on the body, arms, or legs, but not on the face or neck.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- Your lipoma is smaller than 2 inches (5 cm) across.
- Your lipoma is on your trunk, belly, arms, or legs (not on face or neck).
- The lump is soft and movable, not firm or discolored.
- You do not have certain inherited conditions like Li-Fraumeni syndrome or neurofibromatosis.
- You have never had radiation treatment for another cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called Embella (deoxycholic acid) to treat small, stable lipomas (fatty lumps) on your trunk, arms, or legs. The goal is to see if it safely shrinks the lumps without needing surgery.
This study tests an injectable drug (Ronkyla Plus) for shrinking fatty lumps (lipomas). It may be a good option if you have one or more lipomas that have not changed in size for at least 6 months.
This study tests injecting cooled or warmed salt water (saline) into lipomas—harmless fatty lumps under the skin—to see if it can shrink or remove them without surgery. It's for people with a single lipoma or many, as long as they're not on the face, too big, or growing fast.
This trial tests two targeted drugs – mirdametinib and palbociclib – taken as pills for people with a specific aggressive type of liposarcoma (dedifferentiated liposarcoma) that has spread or can't be removed. The goal is to see if this combination can shrink or slow the tumor.
This study looks for a new blood test marker that may help doctors diagnose liposarcoma and estimate how it may behave over time. You may be asked for a blood sample and consent, and the study may follow you to see how well the test works.
This trial tests two experimental drugs (pemigatinib and retifanlimab) for advanced dedifferentiated liposarcoma that has not responded to other treatments. It aims to see if this combination can shrink tumors or slow cancer growth.
Hear when a new Lipoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.